Common features in patients with pathogenic YARS2 mutations are enzyme deficiencies of complexes I, III and IV in muscle, sideroblastic anaemia (although onset and duration may vary between patients), lactic acidosis, and skeletal myopathy and/or cardiomyopathy. This evidence concerns the gene YARS2 and skeletal muscle disorder.